Additionally, the cytotoxic effect of etoposide alone and in combination with trastuzumab or peruzumab was checked in breast cancer cells such as MCF-7 (HER2-) and MDA-MB-231 (HER2-) and HCC1954 (HER2+). Here, ERBB2 is linked to breast cancer.